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NATIONAL INSTITUTES OF HEALTH
WORKSHOP STATEMENT
Reproductive Genetic Testing:
Impact on Women

Reproductive genetic testing, counseling, and other
genetic services can be valuable components in the
reproductive health care of women and their families;
they can also have negative effects on individuals, on
families, and on communities. These services have the
potential to increase knowledge about possible pregnancy outcomes that may occur if a woman decides
to reproduce; provide reassurance during pregnancy;
enhance the developing relationship between the
woman, her expected child, and others; allow a woman
an opportunity to choose whether to continue a pregnancy in which the expected child has a birth defect
or a genetic disorder; and, if continuing, both facilitate
prenatal or early infant therapy for the expected child,
when possible, and prepare the family for bearing and
rearing a child with a disability. Conversely, these services have the potential to increase anxiety; place excessive responsibility, blame, and guilt on a woman
for her pregnancy outcome; interfere with motherinfant bonding; and disrupt relationships between a
woman, family members, and her community.
The challenge is to provide each woman with an
opportunity to have access to desired genetic services,
in a way that will improve her control over the circumstances of her reproductive life, her pregnancies,
childbearing, and parenting, within a framework that
is sensitive to her needs and values and that minimizes
the potential for coercion. The value that women and
their families place on these services depends heavily
on a mixture of psychological and ethno-cultural influences, religious and moral values, and legal and
economic constraints that are unique to each woman.
In addition, it may be influenced by a woman's perceptions about and past experience with people with disabilities. As a consequence, women in different circumstances may weigh the merits of reproductive
genetic services quite differently.
These complex individual differences among women
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challenge efforts to evaluate the safety and efficacy of
reproductive genetic services. To reflect the function
of genetic services in reproductive health care, evaluation criteria must be client centered. That is, beyond
assessment of the biological safety and technical reliability of reproductive genetic services, there should be
assessment to determine whether they fulfill the roles
that their clients define for them. Women may be interested in knowing to what extent reproductive genetic
services can reassure, facilitate planning, and improve
informed decision making, as well as how they can
limit potentially offsetting costs such as the risk for
coercion, increased anxiety, and compromise of their
own values. Further, it may be important to determine
to what extent reproductive genetic services can be
modulated to respect the n~eds and interests of individual women and their families. Research designed tO
evaluate reproductive genetic services in these terms is
urgently needed.
This understanding of reproductive genetic services
has several important implications that should be considered in the development of a future research agenda
in this area.

1. Reproductive genetic services should not be used
to pursue "eugenic" goals but should be aimed at
increasing individuals' control over their own reproductive lives. Therefore, new strategies need to be developed to evaluate the success of such services. Reproductive genetic services must ultimately serve
personal-not public-interests, in improving the
overall reproductive lives of women. Whatever societal gains might be realized through the eugenic use of
reproductive genetic services should be heavily omweighed by the personal needs of women and their
families. The ideals of self-determination in family
matters and respect for individual differences, ideals
that lie behind the client-centered view of reproductive
genetic services, are jeopardized whenever the primary
goal of these services becomes the prevention of the
birth of individuals with a disorder or a disability.
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Such a goal has the potential to constrain the choices
available to women and to further stigmatize those
individuals affected by a particular disorder or disability. To the extent that voluntary reproductive genetic
services are evaluated even indirectly in eugenic terms,
societal pressures have the potential to threaten the
important interests and desires of individual women
and their families.
2. Reproductive genetic services should be meticulously voluntary. Since the primary goal of reproductive genetic services should be to enhance personal
reproductive decisions, such testing should not be
swept in with other "routine" or "universal" reproductive interventions, unless informed consent or refusal
can be assured. Assisting women to give a fully informed consent or refusal to genetics education, testing, and counseling services is at the heart of these
services. Whether reproductive genetic services are
provided by genetics professionals or other health-care
professionals, it is vital that these services be provided
in a non judgmental and noncoercive manner and that
the testing be carried out only after adequate education about their benefits and risks, including those
beyond biology. The success of reproductive genetic
services depends on their ability to effectively empower people to make knowledgeable and informed
decisions. As a result, methods to evaluate the success
or failure of these services should be devised with this
goal in mind.
3. Reproductive genetic services should be value
sensitive. Providers of reproductive genetic services
should be particularly sensitive to individual differences and similarities- including ethno-cultural differences and similarities and various constellations of
beliefs, value commitments, and relationships-and
should adapt their services accordingly. In particular,
providers of reproductive genetic services need to be
aware of their own value system, which has developed
within the context and culture of the biomedical sciences, and to be aware of the language, undertones,
assumptions, and values hidden within their own professions. Training of professionals who will provide
these services should include special emphasis on influences of psychological, sociodemographic, religious and moral values, and ethno-cultural diversity
in women's needs and interests regarding reproductive
genetic testing services. The true impact that the providers' gender, race, ethnicity·, class, and educational
discipline have on how services are provided must be
evaluated.
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4. Standards of care for reproductive genetic services should emphasize genetic information, education, and counseling rather than testing procedures
alone. To the extent that reproductive genetic services
are designed to facilitate personal reproductive planning, providers of reproductive genetic testing and
counseling should tailor their services to meet the
needs and interests of individual women from the beginning. Extreme efforts should be made to assure
that the content of information shared regarding the
disorders for which testing is carried out is comprehensive, accurate, and provided in an unbiased manner,
so that a true picture of what life with such a disability
may be like is presented.
Evaluation measures to determine when women
know enough to have these interests met could serve
to establish professional standards of care that do not
drive providers to encourage testing when it is not
desired. Conversely, sometimes providers do not offer
reproductive genetic testing unless a woman knows
enough to ask for these services. Further evaluation
must be done to determine the balance which must be
reached in educating women so that they have enough
information about these services but do not feel pressure to utilize them when they are not desired.
5. Social, legal, and economic constraints on reproductive genetic services should be removed. Government and institutional policies have continued to influence legal and fiscal rules that limit the reproductive
genetic testing choices that women have available to
them. Research is needed to clarify such constraints
and how they affect the choices and availability of
services. Research is also needed to develop and test
alternative models for delivery that would improve
access and reduce barriers to repwductive genetic services for those women who desire them.
6. Increasing attention focused on the development
and utilization of reproductive genetic testing services
may further stigmatize individuals affected by a particular disorder or disability. The values that some place
on health and disabilities, what people may be told
about disabilities, and even the use of certain language
to describe the benefits of reproductive genetic testing
have the potential to devalue the worth that individuals with disabilities have in society. Both increased
sensitivity to these issues and improved communication between the biomedical and the disability communities are urgently needed in order for the true impact of these developing technologies to become
known. Individuals with disabilities, who have a vari-
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ety of information, experiences, and views to share,
must be involved in the development and implementation of further research to be carried out in this area.
In summary, there are a number of ways that reproductive genetic services may continue to be, in many
cases, less than ideal. This system of care will fail not
only if providers are not informed about and sensitive
to the importance of individual differences among
women, but also if women themselves do not understand the complexity of making decisions about
whether to utilize these services within the context of
their own needs. The future of reproductive genetic
testing within the context of reproductive health care
of women and their families depends on research activities that are aimed at a better understanding of how
best to address these challenges.

Note added in proo}.- This statement and the entire proceedings of this workshop will be published
in the December 1992 issue of Fetal Diagnosis and
Therapy.
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